Dr. Reddy’s inks deal for Covid-19 treatment drug Baricitinib - Android

New Delhi, May 12: Dr Reddy's Laboratories on Tuesday said it has inked a licensing pact with Eli Lilly and Company to produce Baricitinib in the country for treatment of Covid-19. The Hyderabad-based firm said it has entered into a royalty-free,